8-K: Clearwater Analytics Reports Record Q4 Revenue, Fueled by Strong Retention and ARR Growth
Earnings Release
Clearwater Analytics announced strong Q4 and full-year 2024 results, highlighted by record quarterly revenue and a high net revenue retention rate, alongside the planned acquisition of Enfusion.
Summary
- Clearwater Analytics announced its Q4 and full year 2024 financial results.
- Q4 revenue reached a record $126.5 million, a 27.7% increase year-over-year.
- Full year revenue was $451.8 million, up 22.7% year-over-year.
- Annualized Recurring Revenue (ARR) reached $474.9 million, a 25.3% increase year-over-year.
- The net revenue retention rate was a record 116%.
- Net income for Q4 was $420.3 million, significantly up from a net loss of $3.4 million in Q4 2023, primarily due to a one-time income tax benefit of $472 million.
- Adjusted EBITDA for Q4 was $41.7 million, a 39.0% increase year-over-year.
- The company announced its intent to acquire Enfusion, Inc. for $1.5 billion on January 13, 2025.
- First quarter 2025 revenue is expected to be $125 million, with adjusted EBITDA of $41.5 million.
- Full year 2025 revenue is projected to be between $535.5 million and $542 million, with adjusted EBITDA between $182 million and $185 million.
Sentiment
Score: 9
Explanation: The document presents a highly positive outlook with record revenue, strong growth metrics, and a strategic acquisition. The one-time tax benefit significantly boosted net income, and management expresses confidence in future growth.
Positives
- Record quarterly revenue of $126.5 million, up 27.7% year-over-year, indicates strong sales performance.
- ARR growth of 25.3% to $474.9 million demonstrates increasing recurring revenue.
- A net revenue retention rate of 116% shows strong customer loyalty and expansion of existing client relationships.
- The planned acquisition of Enfusion for $1.5 billion is expected to broaden the company's product offerings and market reach.
- The company's platform processes and reports on $8.8 trillion in assets daily, highlighting its significant scale.
Negatives
- Operating cash flows for the fourth quarter of 2024 were negative $28.9 million, impacted by one-time settlement payments of $79 million related to the termination of the Tax Receivable Agreement.
- The company anticipates total equity-based compensation expense and related payroll taxes of approximately $106 million for the full year 2025, which could impact profitability.
Risks
- The company's ability to successfully close the acquisition of Enfusion is subject to closing conditions.
- Successfully integrating Enfusion's operations and technology with Clearwater's is crucial for realizing the expected benefits of the acquisition.
- Retaining Enfusion's employees and clients after the acquisition is important for maintaining business continuity and growth.
- The company faces risks related to rapid technological change, including the development and adoption of artificial intelligence.
- Market volatility and economic downturns could negatively impact the value of assets on the company's platform.
Future Outlook
The company expects Q1 2025 revenue of $125 million and adjusted EBITDA of $41.5 million. Full year 2025 revenue is projected to be between $535.5 million and $542 million, with adjusted EBITDA between $182 million and $185 million. This guidance excludes any impact from the proposed Enfusion acquisition.
Management Comments
- 'Q4 2024 has been nothing short of extraordinary for Clearwater Analytics, as we achieved record revenue of $126.5 million and a record net revenue retention rate of 116%', said Sandeep Sahai, CEO at Clearwater Analytics.
- Sandeep Sahai stated that the acquisition of Enfusion is a 'game changer' that will broaden growth horizons and allow the company to offer a comprehensive front-to-back platform.
Industry Context
Clearwater Analytics' results reflect the increasing demand for SaaS-based investment management solutions. The acquisition of Enfusion positions the company to compete more effectively with firms offering front-to-back solutions, such as BlackRock's Aladdin and SimCorp Dimension.
Comparison to Industry Standards
- Clearwater's net revenue retention rate of 116% is strong compared to the SaaS industry average, which typically ranges from 100% to 120% for mature companies.
- The company's adjusted EBITDA margin of 33% for Q4 2024 is competitive with other SaaS companies in the financial services sector.
- Competitors like SimCorp and FactSet also provide investment management solutions, but Clearwater's focus on a single-instance, multi-tenant architecture differentiates it from some legacy providers.
Stakeholder Impact
- Shareholders will likely react positively to the strong financial results and the strategic acquisition.
- Employees may benefit from the company's growth and expansion opportunities.
- Customers can expect enhanced product offerings and improved service quality.
- Suppliers may see increased business opportunities as the company grows.
- Creditors should be reassured by the company's strong financial performance.
Next Steps
- Complete the acquisition of Enfusion, Inc.
- Integrate Enfusion's operations and technology with Clearwater Analytics.
- Focus on expanding the company's footprint in North America, Europe, and Asia.
- Continue investing in R&D, including Generative AI, to enhance the platform's capabilities.
Key Dates
| Date | Description |
|---|---|
| December 31, 2024 | End of fourth quarter and full year 2024 reporting period. |
| January 13, 2025 | Clearwater Analytics announced its intent to acquire Enfusion, Inc. |
| February 19, 2025 | Announcement of fourth quarter and full year 2024 financial results and conference call. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.